Corticosteroids for herpes zoster: What do they accomplish?

American Journal of Clinical Dermatology

Volumn 3, Issue 8, 2002, Pages 517-524

  Santee, Jennifer A ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; BETAMETHASONE; BUPIVACAINE; CODEINE; CORTICOSTEROID; CORTICOTROPIN; CORTISONE; DEXAMETHASONE; LIDOCAINE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; PROCAINE; TRIAMCINOLONE;

ABSCESS; ARACHNOIDITIS; ASEPTIC MENINGITIS; ATROPHY; BLEEDING; BODY WEIGHT DISORDER; CLINICAL TRIAL; DRUG EFFICACY; FLUSHING; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMAN; HYPERTENSION; MOON FACE; PAIN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; REBOUND; REVIEW; SIDE EFFECT; STEROID THERAPY; THROMBOPHLEBITIS; WEIGHT GAIN;

EID: 0036034269     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200203080-00001     Document Type: Review

References (47)

1. Dwyer DE. Management issues in herpes zoster. Aust Fam Physician 1996; 25: 299-307
2. Mamdani FS. Pharmacologic management of herpes zoster and postherpetic neuralgia. Can Fam Physician 1994; 40: 321-32
3. Ragozzino MW, Melton LJ, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine 1982; 61: 310-6
4. Helgason S, Petursson G, Gudmundsson S, et al. Prevalence of postherpetic neuralgia after a single episode of herpes zoster: Prospective study with long term follow up. BMJ 2000; 321: 1-4
5. Karlin JD. Herpes zoster ophthalmicus: The virus strikes back. Ann Ophthalmol 1993; 25: 208-15
6. Palay DA. Corneal abnormalities. In: Palay DA, Krachmer JH, editors. Ophthalmology for the Primary Care Physician. St Louis (MO): Mosby-Year Book, Inc., 1997: 68-79
7. Pavan-Langston D. Herpes zoster ophthalmicus. Neurology 1995; 45 Suppl. 8: S50-1
8. Kost RG, Straus SE. Drug therapy: Postherpetic neuralgia - Pathogenesis, treatment and prevention. N Engl J Med 1996; 335: 32-42
9. Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia: A systematic review of the literature. J Fam Pract 2000; 49: 255-64
10. Dickinson JA. Should we treat herpes zoster with corticosteroid agents. Med J Aust 1986; 144: 375-80
11. Cunningham ET. Diagnosing and treating herpetic anterior Uveitis. Ophthalmology 2000; 107: 2129-30
12. Ernst ME, Santee JA, Klepser T. Oral corticosteroids for pain associated with herpes zoster. Ann Pharmacother 1998; 32: 1099-103
13. Elliott FA. Treatment of herpes zoster with high doses of prednisone. Lancet 1964; 11: 610-1
14. Eaglstein WH, Katz R, Brown JA. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA 1970; 211: 1681-3
15. Keczkes K, Basheer AM. Do corticosteroids prevent post-herpetic neuralgia? Br J Dermatol 1980; 102: 551-5
16. Clemmensen OJ, Andersen KE. ACTH versus prednisone and placebo in herpes zoster treatment. Clin Exp Dermatol 1984; 9: 557-63
17. Esmann V, Kroon S, Peterslund NA, et al. Prednisolone does not prevent postherpetic neuralgia. Lancet 1987; II: 126-9
18. Bendoli D, Mirizzi S, Zucchi A, et al. Prevention of post-herpetic neuralgia: Evaluation of treatment with oral prednisone, oral acyclovir, and radiotherapy. Int J Dermatol 1991; 30: 288-90
19. Calza AM, Schmied E, Harms M. Systemic corticosteroids do not prevent postherpetic neuralgia. Dermatology 1992; 184: 314-6
20. Wood MJ, Johnson RW, McKendrick MW, et al. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330: 896-0
21. Whitley RJ, Weiss H, Gnann W, et al. Acyclovir with and without prednisone for the treatment of herpes zoster. Ann Intern Med 1996; 125: 376-83
22. Merselis JG, Kaye D, Hook EW. Disseminated herpes zoster: A report of 17 cases. Arch Intern Med 1964; 113: 679-86
23. Pasqualucci A, Pasqualucci V, Galla F, et al. Prevention of post-herpetic neuralgia: Acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand 2000; 44: 910-8
24. McGill J. Topical acyclovir in herpes zoster ocular involvement. Br J Ophthalmol 1981; 65: 542-5
25. McGill J, Chapman C. A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis. Br J Ophthalmol 1983; 67: 746-50
26. McGill J. Herpes zoster ocular infection. Scand J Infect Dis 1985; 17 Suppl. 47: 85-8
27. Marsh RJ, Cooper M. Double-masked trial of topical acyclovir and steroids in the treatment of herpes ocular inflammation. Br J Ophthalmol 1991; 75: 542-6
28. Collum LMT, Hillery M, McDermott M, et al. The management of herpes zoster ophthalmicus. Bull Soc Belge Ophthalmol 1987; 224: 9-14
29. Perkins HM, Hanlon PR. Epidural injection of local anesthetic and steroids for relief of pain secondary to herpes zoster. Arch Surg 1978; 113: 253-4
30. Schreuder M. Pain relief in herpes zoster. S Afr Med J 1983; 63: 820-1
31. Forrest JB. Management of chronic dorsal root pain with epidural steroid. Can Anaesth Soc J 1978; 25: 218-25
32. Appelman DH. Treatment of herpes zoster with ACTH. N Engl J Med 1955; 253: 693-5
33. Epstein E. Triamcinolone-procaine in the treatment of zoster and postzoster neuralgia. Calif Med 1971; 115: 6-10
34. Epstein E. Treatment of herpes zoster and postzoster neuralgia by the intralesional injection of triamcinolone: A computer analysis of 199 cases. Int J Dermatol 1976; 15: 762-9
35. Chiarello SE. Tumescent infiltration of corticosteroids, lidocaine, and epinephrine into dermatomes of acute herpetic pain or postherpetic neuralgia. Arch Dermatol 1998; 134: 279-81
36. Kikuchi A, Naoki K, Sato T, et al. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 1999; 24: 287-93
37. Kotani N, Kushikata T, Hashimoto H, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000; 343: 1514-9
38. Gelfand ML. Treatment of herpes zoster with cortisone. JAMA 1954; 154: 911-2
39. Watson CPN. A new treatment for postherpetic neuralgia. N Engl J Med 2000; 343: 1563-5
40. Abram SE. Intrathecal steroid injection for postherpetic neuralgia: What are the risks? Reg Anesth Pain Med 1999; 24: 283-5
41. Nelson DA, Landau WM. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 2001; 344: 1019
42. Lampe JB. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 2001; 344: 1019-20
43. Niebergall H. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 2001; 344: 1020
44. Zetlaoui PJ, Cosserat J. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 2001; 344: 1020-1
45. Lewis G. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 2001; 344: 1020
46. Nelson DA. Dangers from methylprednisolone acetate therapy by intraspinal injection. Arch Neurol 1988; 45: 804-6
47. Kotani N. Intrathecal methylprednisolone for postherpetic neuralgia. N Engl J Med 2001; 344: 1019-22